Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-058995
Filing Date
2025-06-27
Accepted
2025-06-27 16:01:51
Documents
8
Effectiveness Date
2025-06-27

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0246580-s8_abvc.htm S-8 70084
2 OPINION OF HUNTER TAUBMAN FISCHER & LI LLC ea024658001ex5-1_abvc.htm EX-5.1 18597
3 SECOND AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN ea024658001ex10-3_abvc.htm EX-10.3 69855
4 CONSENT OF SIMON & EDWARD, LLP ea024658001ex23-1_abvc.htm EX-23.1 3539
5 FILING FEE TABLE ea024658001ex-fee_abvc.htm EX-FILING FEES 10060
6 GRAPHIC ex5-1_001.jpg GRAPHIC 6747
7 GRAPHIC ex23-1_001.jpg GRAPHIC 26110
8 GRAPHIC ex23-1_002.jpg GRAPHIC 2957
  Complete submission text file 0001213900-25-058995.txt   223191
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288377 | Film No.: 251086174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)